Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1281, 2001-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Celecoxib: safety benefits yield cost savings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. :
Access to resources
Recommend
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Cost effectiveness of celecoxib, rofecoxib in OA and RA
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Celecoxib: low cost alternative in OA and RA
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :